APOBEC3B can impair genomic stability by inducing base substitutions in genomic DNA in human cells

Scientific Reports

Volumn 2, Issue , 2012, Pages

  Shinohara, Masanobu ^a   Io, Katsuhiro ^a   Shindo, Keisuke ^a   Matsui, Masashi ^a   Sakamoto, Takashi ^a   Tada, Kohei ^a   Kobayashi, Masayuki ^a   Kadowaki, Norimitsu ^a   Takaori Kondo, Akifumi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOBEC3B PROTEIN, HUMAN; CYTIDINE DEAMINASE; ENHANCED GREEN FLUORESCENT PROTEIN; GREEN FLUORESCENT PROTEIN; ISOPROTEIN; MYC PROTEIN;

ARTICLE; CELL STRAIN HEK293; GENETIC TRANSFECTION; GENETICS; GENOMIC INSTABILITY; HUMAN; HUMAN GENOME; METABOLISM; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; TUMOR CELL LINE;

BASE SEQUENCE; CELL LINE, TUMOR; CYTIDINE DEAMINASE; GENOME, HUMAN; GENOMIC INSTABILITY; GREEN FLUORESCENT PROTEINS; HEK293 CELLS; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS C-MYC; TRANSFECTION;

EID: 84869159477     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep00806     Document Type: Article

References (51)

1. Hahn, W. C.&Weinberg, R. A. Rules for making human tumor cells.NEngl J Med 347, 1593-603 (2002). (Pubitemid 35315841)
2. Pleasance, E. D. et al. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 463, 191-6 (2010).
3. Bronner, C. E. et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 368, 258-61 (1994).
4. Greenman, C. et al. Patterns of somatic mutation in human cancer genomes. Nature 446, 153-8 (2007). (Pubitemid 46398669)
5. Prickett, T. D. et al.Analysis of the tyrosine kinome inmelanoma reveals recurrent mutations in ERBB4. Nat Genet 41, 1127-32 (2009).
6. Macduff, D. A. & Harris, R. S. Directed DNA deamination by AID/APOBEC3 in immunity. Curr Biol 16, R186-9 (2006).
7. Conticello, S. G. The AID/APOBEC family of nucleic acid mutators. Genome Biol 9, 229 (2008).
8. Muramatsu, M. et al. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102, 553-63 (2000).
9. Matsumoto, Y. et al. Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nat Med 13, 470-6 (2007). (Pubitemid 46559833)
10. Yoshikawa, K. et al. AID enzyme-induced hypermutation in an actively transcribed gene in fibroblasts. Science 296, 2033-6 (2002). (Pubitemid 34627527)
11. Okazaki, I. M. et al. Constitutive expression of AID leads to tumorigenesis. J Exp Med 197, 1173-81 (2003).
12. Pasqualucci, L. et al. AID is required for germinal center-derived lymphomagenesis. Nat Genet 40, 108-12 (2008).
13. Endo, Y. et al. Activation-induced cytidine deaminase links between inflammation and the development of colitis-associated colorectal cancers. Gastroenterology 135, 889-98, 898 e1-3 (2008).
14. Jarmuz, A. et al. An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics 79, 285-96 (2002). (Pubitemid 34211936)
15. Goila-Gaur, R. & Strebel, K. HIV-1 Vif, APOBEC, and intrinsic immunity. Retrovirology 5, 51 (2008).
16. Mangeat, B. et al. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424, 99-103 (2003). (Pubitemid 36834849)
17. Bogerd, H. P. et al. Cellular inhibitors of long interspersed element 1 and Alu retrotransposition. Proc Natl Acad Sci USA 103, 8780-5 (2006). (Pubitemid 43878096)
18. Landry, S., Narvaiza, I., Linfesty, D. C. & Weitzman, M. D. APOBEC3A can activate the DNA damage response and cause cell-cycle arrest. EMBO Rep 12, 444-50 (2011).
19. Suspène, R. et al. Somatic hypermutation of human mitochondrial and nuclear DNA by APOBEC3 cytidine deaminases, a pathway for DNA catabolism. Proc Natl Acad Sci USA 108, 4858-63 (2011).
20. Lackey, L. et al. APOBEC3B and AID have similar nuclear import mechanisms. J Mol Biol 419, 301-14 (2012).
21. Kinomoto, M. et al. All APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition. Nucleic Acids Res 35, 2955-64 (2007). (Pubitemid 47073634)
22. Bogerd, H. P., Wiegand, H. L., Doehle, B. P. & Cullen, B. R. The intrinsic antiretroviral factor APOBEC3B contains two enzymatically active cytidine deaminase domains. Virology 364, 486-93 (2007). (Pubitemid 46873711)
23. Suspène, R. et al. Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo. Proc Natl Acad Sci USA 102, 8321-6 (2005). (Pubitemid 40800087)
24. Bonvin, M. & Greeve, J. Effects of point mutations in the cytidine deaminase domains of APOBEC3B on replication and hypermutation of hepatitis B virus in vitro. J Gen Virol 88, 3270-4 (2007). (Pubitemid 350201836)
25. Stenglein, M. D., Burns, M. B., Li, M., Lengyel, J. & Harris, R. S. APOBEC3 proteins mediate the clearance of foreign DNA from human cells. Nat Struct Mol Biol 17, 222-9 (2010).
26. Suspène, R., Henry, M., Guillot, S., Wain-Hobson, S.&Vartanian, J. P. Recovery of APOBEC3-edited human immunodeficiency virus G-.A hypermutants by differential DNA denaturation PCR. J Gen Virol 86, 125-9 (2005). (Pubitemid 40081158)
27. Vartanian, J. P. et al. Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis. PLoS Pathog 6, e1000928 (2010).
28. Bishop, K. N. et al. Cytidine deamination of retroviral DNA by diverse APOBEC proteins. Curr Biol 14, 1392-6 (2004). (Pubitemid 39081643)
29. Harris, R. S. et al. DNA deamination mediates innate immunity to retroviral infection. Cell 113, 803-9 (2003). (Pubitemid 36724943)
30. Beale, R. C. et al. Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo. J Mol Biol 337, 585-96 (2004). (Pubitemid 38326879)
31. Greeve, J. et al. Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas. Blood 101, 3574-80 (2003). (Pubitemid 36857944)
32. Deutsch, A. J. et al. MALT lymphoma and extranodal diffuse large B-cell lymphoma are targeted by aberrant somatic hypermutation. Blood 109, 3500-4 (2007). (Pubitemid 46572541)
33. Pasqualucci, L. et al. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 412, 341-6 (2001). (Pubitemid 32691848)
34. Kotani, A. et al.Atarget selection of somatic hypermutations is regulated similarly between T and B cells upon activation-induced cytidine deaminase expression. Proc Natl Acad Sci USA 102, 4506-11 (2005). (Pubitemid 40397142)
35. Smit, L. A. et al. Expression of activation-induced cytidine deaminase is confined to B-cell non-Hodgkin's lymphomas of germinal-center phenotype. Cancer Res 63, 3894-8 (2003). (Pubitemid 36917901)
36. Chen, H. et al. APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons. Curr Biol 16, 480-5 (2006). (Pubitemid 43343708)
37. Mottok, A., Hansmann, M. L. & Bräuninger, A. Activation induced cytidine deaminase expression in lymphocyte predominant Hodgkin lymphoma. J Clin Pathol 58, 1002-4 (2005). (Pubitemid 41265294)
38. Kato, M. et al. Frequent inactivation of A20 in B-cell lymphomas. Nature 459, 712-6 (2009).
39. Delker, R. K., Fugmann, S. D. & Papavasiliou, F. N. A coming-of-age story: activation-induced cytidine deaminase turns 10. Nat Immunol 10, 1147-53 (2009).
40. Crouch, E. E. et al. Regulation of AID expression in the immune response. J Exp Med 204, 1145-56 (2007). (Pubitemid 46798157)
41. Gonda, H. et al. The balance between Pax5 and Id2 activities is the key to AID gene expression. J Exp Med 198, 1427-37 (2003). (Pubitemid 37392487)
42. Pauklin, S., Sernández, I. V., Bachmann, G., Ramiro, A. R. & Petersen-Mahrt, S. K. Estrogen directly activates AID transcription and function. J Exp Med 206, 99-111 (2009).
43. Teng, G. et al. MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. Immunity 28, 621-9 (2008).
44. de Yébenes, V. G. et al.miR-181b negatively regulates activation-induced cytidine deaminase in B cells. J Exp Med 205, 2199-206 (2008).
45. Ito, S. et al. Activation-induced cytidine deaminase shuttles between nucleus and cytoplasm like apolipoprotein B mRNA editing catalytic polypeptide 1. Proc Natl Acad Sci USA 101, 1975-80 (2004). (Pubitemid 38229000)
46. Patenaude, A. M. et al. Active nuclear import and cytoplasmic retention of activation-induced deaminase. Nat Struct Mol Biol 16, 517-27 (2009).
47. Basu, U. et al. The AID antibody diversification enzyme is regulated by protein kinase A phosphorylation. Nature 438, 508-11 (2005). (Pubitemid 41742023)
48. McBride, K. M. et al. Regulation of class switch recombination and somatic mutation by AID phosphorylation. J Exp Med 205, 2585-94 (2008).
49. Koning, F. A. et al. Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets. J Virol 83, 9474-85 (2009).
50. Berger, G. et al. APOBEC3A is a specific inhibitor of the early phases of HIV-1 infection in myeloid cells. PLoS Pathog 7, e1002221 (2011).
51. Shirakawa, K. et al. Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif. Nat Struct Mol Biol 15, 1184-91 (2008).